A Theoretical Study of Phosphoryl Transfers of Tyrosyl-DNA Phosphodiesterase I (Tdp1) and the Possibility of a "Dead-End" Phosphohistidine Intermediate

被引:20
|
作者
DeYonker, Nathan J. [2 ]
Webster, Charles Edwin [1 ,2 ]
机构
[1] Mississippi State Univ, Dept Chem, Mississippi State, MS 39762 USA
[2] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
基金
美国国家科学基金会;
关键词
STRAND BREAK REPAIR; SITE-DIRECTED MUTAGENESIS; CHEMICAL CLUSTER APPROACH; EFFECTIVE CORE POTENTIALS; DEPENDENT PROTEIN-KINASE; TRANSITION-STATE ANALOG; PHOSPHOLIPASE-D; ACTIVE-SITE; SPINOCEREBELLAR ATAXIA; COVALENT COMPLEXES;
D O I
10.1021/acs.biochem.5b00396
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tyrosyl-DNA phosphodiesterase I (Tdp1) is a DNA repair enzyme conserved across eukaryotes that catalyzes the hydrolysis of the phosphodiester bond between the tyrosine residue of topoisomerase I and the 3'-phosphate of DNA. Atomic level details of the mechanism of Tdp1 are proposed and analyzed using a fully quantum mechanical, geometrically constrained model. The structural basis for the computational model is the vanadate-inhibited crystal structure of human Tdp1 (hTdp1, Protein Data Bank entry 1RFF). Density functional theory computations are used to acquire thermodynamic and kinetic data along the catalytic pathway, including the phosphoryl transfer and subsequent hydrolysis. Located transition states and intermediates along the reaction coordinate suggest an associative phosphoryl transfer mechanism with five-coordinate phosphorane intermediates. Similar to both theoretical and experimental results for phospholipase D, the proposed mechanism for hTdp1 also includes the thermodynamically favorable possibility of a four-coordinate phosphohistidine "dead-end" product.
引用
收藏
页码:4236 / 4247
页数:12
相关论文
共 50 条
  • [41] Excision of Carbohydrate-Modified dNMP Analogues from DNA 3' end by Human Apurinic/Apyrimidinic Endonuclease 1 (APE1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1)
    Dyrkheeva, N. S.
    Lebedeva, N. A.
    Sherstyuk, Yu. V.
    Abramova, T. V.
    Silnikov, V. N.
    Lavrik, O. I.
    MOLECULAR BIOLOGY, 2018, 52 (06) : 922 - 928
  • [42] Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)-Topoisomerase I (Top1) Inhibitors (vol 55, pg 4457, 2012)
    Nguyen, Trung Xuan
    Morrell, Andrew
    Conda-Sheridan, Martin
    Marchand, Christophe
    Agama, Keli
    Bermingham, Alun
    Stephen, Andrew G.
    Chergui, Adel
    Naumova, Alena
    Fisher, Robert
    O'Keefe, Barry R.
    Pommier, Yves
    Cushman, Mark
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) : 7297 - 7297
  • [43] Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions
    Plo, I
    Liao, ZY
    Barceló, JM
    Kohlhagen, G
    Caldecott, KW
    Weinfeld, M
    Pommier, Y
    DNA REPAIR, 2003, 2 (10) : 1087 - 1100
  • [44] Synthesis of furanotriterpenoids from betulin and evaluation of Tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitory properties of new semi-synthetic triterpenoids
    Tolmacheva, Irina
    Eroshenko, Daria
    Chernyshova, Irina
    Nazarov, Mikhail
    Lavrik, Olga
    Grishko, Victoria
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 276
  • [45] Excision of Carbohydrate-Modified dNMP Analogues from DNA 3' end by Human Apurinic/Apyrimidinic Endonuclease 1 (APE1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1)
    N. S. Dyrkheeva
    N. A. Lebedeva
    Yu. V. Sherstyuk
    T. V. Abramova
    V. N. Silnikov
    O. I. Lavrik
    Molecular Biology, 2018, 52 : 922 - 928
  • [46] Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures
    Davies, DR
    Interthal, H
    Champoux, JJ
    Hol, WGJ
    JOURNAL OF MOLECULAR BIOLOGY, 2002, 324 (05) : 917 - 932
  • [47] New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties
    Khomenko, Tatyana
    Zakharenko, Alexandra
    Odarchenko, Tatyana
    Arabshahi, Homayon John
    Sannikova, Victoriya
    Zakharova, Olga
    Korchagina, Dina
    Reynisson, Johannes
    Volcho, Konstantin
    Salakhutdinov, Nariman
    Lavrik, Olga
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5573 - 5581
  • [48] Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents
    Zhang, Xiao-Ru
    Wang, Hao-Wen
    Tang, Wen-Lin
    Zhang, Yu
    Yang, Hui
    Hu, De-Xuan
    Ravji, Azhar
    Marchand, Christophe
    Kiselev, Evgeny
    Ofori-Atta, Kwabena
    Agama, Keli
    Pommier, Yves
    An, Lin-Kun
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (22) : 9908 - 9930
  • [49] Tyrosyl-DNA phosphodiesterase 1 (TDP1) is critical for the repair of DNA breaks induced by sapacitabine, a nucleoside antimetabolite in clinical trials targeted to ATM- and BRCA-deficient tumors
    Al Abo, Muthana
    Liu, Xiaojun
    Plunkett, William
    Pommier, Yves
    CANCER RESEARCH, 2015, 75
  • [50] In Vitro and In Silico Studies of Human Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) Inhibition by Stereoisomeric Forms of Lipophilic Nucleosides: The Role of Carbohydrate Stereochemistry in Ligand-Enzyme Interactions
    Dyrkheeva, Nadezhda S.
    Chernyshova, Irina A.
    Ivanov, Georgy A.
    Porozov, Yuri B.
    Zenchenko, Anastasia A.
    Oslovsky, Vladimir E.
    Zakharenko, Alexandra L.
    Nasyrova, Darina, I
    Likhatskaya, Galina N.
    Mikhailov, Sergey N.
    Lavrik, Olga, I
    Drenichev, Mikhail S.
    MOLECULES, 2022, 27 (08):